Author: <span>Latest News on: home</span>

Aduro Announces ASCO Presentation of Promising Results from Phase 1b…

CHICAGO & BERKELEY, Calif. — — Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standar…